Assessment of a pregnant woman and her fetus reveals tachycardia and hypertension. There is also evidence suggesting vasoconstriction. The nurse would question the woman about use of which substance?
Marijuana
Cocaine
Nicotine
Caffeine
Heroin
The Correct Answer is B
Choice A Reason: This is incorrect because marijuana is a psychoactive substance that affects the central nervous system and can cause euphoria, relaxation, altered perception, and impaired memory. It does not cause tachycardia, hypertension, or vasoconstriction in pregnant women or their fetuses.
Choice B Reason: This is correct because cocaine is a stimulant substance that affects the cardiovascular system and can cause tachycardia, hypertension, vasoconstriction, arrhythmias, and ischemia in pregnant women or their fetuses. It can also increase the risk of placental abruption, preterm labor, intrauterine growth restriction, and fetal death.
Choice C Reason: This is incorrect because nicotine is a stimulant substance that affects the respiratory system and can cause bronchodilation, increased heart rate, and increased blood pressure in pregnant women or their fetuses. However, it does not cause vasoconstriction, but rather vasodilation.
Choice D Reason: This is incorrect because caffeine is a stimulant substance that affects the central nervous system and can cause alertness, insomnia, anxiety, and increased urine output in pregnant women or their fetuses. It does not cause tachycardia, hypertension, or vasoconstriction in moderate doses.
Choice E Reason: This is incorrect because heroin is an opioid substance that affects the central nervous system and can cause euphoria, sedation, analgesia, and respiratory depression in pregnant women or their fetuses. It does not cause tachycardia, hypertension, or vasoconstriction.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is C
Explanation
Choice A Reason: This is incorrect because administering Rho(D) immune globulin 24 hours before delivery is too early and may not provide adequate protection for the fetus. Administering it 24 hours after delivery is too late and may not prevent the mother from developing antibodies against the fetal Rh-positive blood cells.
Choice B Reason: This is incorrect because administering Rho(D) immune globulin in the first trimester is unnecessary and may not be effective, as the risk of Rh isoimmunization is very low before 28 weeks of gestation. Administering it within 2 hours of delivery is appropriate, but not sufficient, as it should be repeated within 72 hours after delivery.
Choice C Reason: This is correct because administering Rho(D) immune globulin at 28 weeks gestation and again within 72 hours after delivery is the recommended schedule for preventing Rh isoimmunization in Rh-negative pregnant women who have Rh-positive partners. This regimen can prevent up to 99% of cases of Rh isoimmunization by blocking the maternal immune response to the fetal Rh-positive blood cells.
Choice D Reason: This is incorrect because administering Rho(D) immune globulin at 32 weeks gestation is too late and may not prevent Rh isoimmunization if there has been any fetal-maternal hemorrhage before that time. Administering it immediately before discharge is also too late and may not prevent the mother from developing antibodies against the fetal Rh-positive blood cells.
Correct Answer is C
Explanation
Choice A Reason: This is incorrect because administering Rho(D) immune globulin 24 hours before delivery is too early and may not provide adequate protection for the fetus. Administering it 24 hours after delivery is too late and may not prevent the mother from developing antibodies against the fetal Rh-positive blood cells.
Choice B Reason: This is incorrect because administering Rho(D) immune globulin in the first trimester is unnecessary and may not be effective, as the risk of Rh isoimmunization is very low before 28 weeks of gestation. Administering it within 2 hours of delivery is appropriate, but not sufficient, as it should be repeated within 72 hours after delivery.
Choice C Reason: This is correct because administering Rho(D) immune globulin at 28 weeks gestation and again within 72 hours after delivery is the recommended schedule for preventing Rh isoimmunization in Rh-negative pregnant women who have Rh-positive partners. This regimen can prevent up to 99% of cases of Rh isoimmunization by blocking the maternal immune response to the fetal Rh-positive blood cells.
Choice D Reason: This is incorrect because administering Rho(D) immune globulin at 32 weeks gestation is too late and may not prevent Rh isoimmunization if there has been any fetal-maternal hemorrhage before that time. Administering it immediately before discharge is also too late and may not prevent the mother from developing antibodies against the fetal Rh-positive blood cells.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today